Skip to main content
DEINOVE logo

DEINOVE — Investor Relations & Filings

Ticker · ALDEI ISIN · FR0010879056 LEI · 969500BEJSRFER0F2K08 PA Professional, scientific and technical activities
Open in API
Filings indexed 300 across all filing types
Latest filing 2021-03-10 Regulatory Filings
Country FR France
Listing PA ALDEI

About DEINOVE

https://www.deinove.com

DEINOVE is a biotechnology company that discovers, develops, and produces high-value compounds derived from rare bacteria and microorganisms, often referred to as 'microbial dark matter'. Leveraging a proprietary technology platform, the company harnesses the metabolic potential of extremophilic bacteria, such as Deinococcus, to create innovative solutions. Its primary applications are focused on developing novel bio-based active ingredients, including carotenoids, for the cosmetics sector, and discovering new antibiotics to address the global challenge of antimicrobial resistance.

Recent filings

Filing Released Lang Actions
DEINOVE bénéficie du soutien de l’Etat, dans le cadre du plan France Relance, pour accélérer le développement de nouveaux antimicrobiens
Regulatory Filings Classification · 1% confidence The document is a formal announcement from DEINOVE dated March 10, 2021, detailing that its project 'Boost-ID' has been selected by the French State under the 'France Relance' plan to receive funding (500 to 800 k€) to accelerate the development of new antimicrobials using microfluidics technology. This content structure—a headline announcing a specific event (funding/grant approval), key bullet points summarizing the news, detailed commentary, and contact information—is characteristic of a press release or an initial announcement of financial/strategic news, rather than a comprehensive periodic report (like 10-K or IR) or a transcript. Since it is the initial release of key financial/strategic highlights regarding government support and project acceleration, it best fits the 'Earnings Release' category (ER) as a proxy for a significant operational/strategic announcement, or potentially 'Regulatory Filings' (RNS) if it were a mandatory filing. Given the focus on strategic operational progress and funding news, and lacking specific quarterly/annual financial tables, 'ER' (Earnings Release, often used broadly for key operational updates) or 'RPA' (Report Publication Announcement) are candidates. However, this is the news itself, not an announcement *about* a report. Since it details strategic progress and funding, and is not a standard 10-K, IR, or a simple notice of a dividend/share transaction, 'ER' is the closest fit for a major, time-sensitive operational update, although 'RNS' (Regulatory Filings/General Announcement) is also plausible. Given the nature of the announcement (strategic funding win), I will classify it as an 'ER' as it serves as the primary communication of a significant operational milestone, similar to how earnings are communicated.
2021-03-10 French
DEINOVE benefits from the support of the French government, within the framework of the “France Relance” plan, to accelerate the development of new antimicrobials
Regulatory Filings Classification · 1% confidence The document is a press release dated March 10, 2021, announcing that DEINOVE's Boost-ID project was selected for funding under the French government's "France Relance" plan. It details the project, its expected grant amount, and its strategic importance for developing new antimicrobials. This type of announcement, which details specific operational or strategic developments, funding awards, or project milestones outside of routine financial reporting (like 10-K or ER), typically falls under a general regulatory announcement category. Since it is not a formal financial report (10-K, IR, ER), a management discussion (MDA), or a capital event (CAP), the most appropriate classification is Regulatory Filings (RNS), which serves as a general category for significant, non-standard corporate news releases that are regulatory in nature but don't fit other specific codes. The length is moderate, but the content is a news announcement, not a formal report.
2021-03-10 English
L’équipe Business développement de DEINOVE se renforce pour déployer la stratégie de partenariats de la Société
Board/Management Information Classification · 1% confidence The document announces the reinforcement of DEINOVE's Business Development team with two new hires (Hervé ANSANAY and Corentin CHABOUD) to deploy the company's partnership strategy and secure non-dilutive funding. This type of announcement, detailing changes in senior personnel responsible for strategy and business operations, directly corresponds to the definition of Board/Management Information (MANG). It is not a formal financial report (10-K, IR), an earnings release (ER), or a proxy statement (DEF 14A/PSI).
2021-01-21 French
DEINOVE strengthens its Business development team to deploy its partnering strategy
Board/Management Information Classification · 1% confidence The document announces specific appointments to the company's Business Development team: Hervé ANSANAY as Director and Corentin CHABOUD as Grant Officer. This content directly relates to changes in senior personnel and management structure. This aligns perfectly with the definition for Board/Management Information (MANG), which covers 'Announcement of changes in the company's board of directors or senior management.' It is not a financial report (10-K, IR, ER), a shareholder vote result (DVA), or a general regulatory filing (RNS), as the subject matter is highly specific to management structure changes.
2021-01-21 English
Issuance of a 5th tranche of 3 millions EUR of notes convertible into new shares
Capital/Financing Update Classification · 1% confidence The document explicitly announces the 'ISSUANCE OF A 5th TRANCHE OF 3 MILLIONS EUR OF NOTES CONVERTIBLE INTO NEW SHARES'. This action relates directly to the company's financing activities and capital structure (issuing convertible notes). This aligns perfectly with the definition for Capital/Financing Update (CAP). The document is a press release detailing a specific financial transaction, not a general report or a mere announcement of a report's publication.
2021-01-20 English
Emission d’une 5ème tranche d'OCA de 3 m€
Capital/Financing Update Classification · 1% confidence The document is titled 'Communiqué de presse' (Press Release) and announces the 'EMISSION D'UNE 5ème TRANCHE D'OCA DE 3 M€' (Issuance of a 5th tranche of OCA for €3M). OCA stands for Obligations Convertibles en Actions (Convertible Bonds). This action directly relates to the company raising capital or changing its financing structure. Based on the definitions, this fits best under 'Capital/Financing Update' (CAP), as it details the subscription of new convertible bonds to reinforce treasury for clinical trials. It is not an earnings release (ER), an interim report (IR), or a general regulatory filing (RNS), as it describes a specific financing event.
2021-01-20 French

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.